The case of myelodysplastic syndrome after 65 years old

Paulina Kasperska, Eliza Oleksy, Anna Ziółkowska, Wojciech Stemplowski, Remigiusz Sokołowski, Karolina Klimkiewicz-Wszelaki, Katarzyna Piotrowska, Kornelia Kędziora-Kornatowska, Walery Zukow


Background. The etiology of MDS syndromes (myelodysplastic syndromes) is unknown. MDS is a disease of the elderly, mostly affects people over 50 years of age. Elderly patients with MDS are diagnosed at an earlier stage of the disease compared to younger people. Therapeutic options in MDS include treatment with high-dose chemotherapy with / without hematopoietic stem cell transplantation, treatment with low-dose chemotherapy, supportive care and symptomatic treatment. Transfusion of RBC (Red Blood Cells) concentrate and platelet concentrate is used in the majority of patients with MDS and it is the only form of therapy recommended for both patients with good and bad prognosis.
Case report. A 77-year-old patient repeatedly hospitalized in the Clinic of Geriatrics for symptomatic anemia in myelodysplastic syndrome. Independent patient in the field of self-care, living alone. Patient take many medicines from different groups. Patient with multidisease. Symptoms of the patient: weakness, depressed mood, reduced tolerance of physical exercise, dizziness, palpitations associated with slight physical effort, symptoms of gastrointestinal bleeding, stenocardial complaints in 2017. A bone marrow biopsy was performed - in the myelogram MDS was diagnosed with features of low-grade triplicate dysplasia. Patient repeatedly hospitalized for transfusion of Irradiated Leukocyte-Depleted RBC Concentrate (since the beginning of 2018 11 times - average 1 x / month). From October 2012 to November 2018, a total of 49 Irradiated Leukocyte-Depleted RBC Concentrates units were transfused, reducing only the symptoms of the disease.
Results. A careful assessment of the functional status, ability to tolerate treatment, disease progression and overall health can be helpful in determining treatment. To improve access to treatment, emphasis should be placed on oral drug therapies that can be easily administered on an outpatient basis to minimize transfusion. Palliative care and environmental care are important aspects of improving the health and quality of life of MDS patients.


myelodysplastic syndrome; older age; case study

Full Text:



Sawczuk-Chabin J, Seferyńska I. Leczenie zespołów mielodysplastycznych. [Treatment of myelodysplastic syndromes]. Postępy Nauk Medycznych. (2003); 3-4: 93-98 (in Polish).

Kata D, Kyrcz-Krzemień S. Zespoły mielodysplastyczne – współczesna diagnostyka, klasyfikacja i leczenie. Część II: Opcje terapeutyczne w zespołach mielodysplastycznych. [Myelodysplastic syndromes - contemporary diagnostics, classification and treatment. Part II: Therapeutic options in myelodysplastic syndromes]. Postępy Nauk Medycznych. 2011; 24(6): 504-511 (in Polish).

Cioch M. Zespoły mielodysplastyczne. [Myelodysplastic syndromes]. Zamojskie Studia i Materiały. (2011); 13(4): 65-68 (in Polish).

Komarnicki M, Szymala K. Zespoły mielodysplastyczne. [Myelodysplastic syndromes]. Współczesna Onkologia. (2003); 7(9): 692-70 (in Polish).

Kata D, Kyrcz-Krzemień S. Zespoły mielodysplastyczne – współczesna diagnostyka, klasyfikacja i leczenie Część I: Diagnostyka, klasyfikacja i stratyfikacja prognostyczna zespołów mielodysplastycznych. [Myelodysplastic syndromes - contemporary diagnostics, classification and treatment Part I: Diagnosis, classification and prognostic stratification of myelodysplastic syndromes]. Postępy Nauk Medycznych . (2011); 6: 499-503 (in Polish).

Dmoszyńska A, Giannopoulos K. Nowotwory hematologiczne wieku starszego. [Hematologic neoplasms of the elderly]. Postępy Biologii Komórki. (2005); 32(1): 115-124.

Argento V, Roylance J, Skudlarska B, Dainiak N, Amoateng-Adjepong Y. Anemia Prevalence in a Home Visit Geriatric Population. Journal of the American Medical Directors Association. (2008); 9(6): 422-426.

Jansen A, Essink‐Bot M, Beckers E, Hop W, Schipperus M, Van Rhenen D. Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes. British Yournal of Heamatology. (2003); 121(2): 270-274.

Stauder R. The challenge of individualized risk assessment and therapy planning in eldery high-risk myelodysplastic syndromes (MDS) patients. Annals of Hematology. (2012); 91(9): 1333-1343.

Ma X, Does M, Raza A, Mayne S. Myelodysplastic syndromes. Cancer. (2007); 109(8): 1536-1542.

Dewulf G, Gouin I, Pautas E, Gaussem P, Chaïbi P, Andreux J, Siguret V. Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients. Annales de Biologie Clinique. (2004); 62(2): 197-202.

Niscola P, Palombi M, Trawinska M, Tendas A, Giovannini M, Scaramucci L, Perrotti A, Fabritiis P. Managing myelodysplastic syndromes in very old patients: a teaching case report. Clinical Interventions in Aging. (2013); 8: 391-394.

Kurtin S. Myelodysplastic syndromes: diagnosis, treatment, planning, and clinical management. Oncology Journal. (2007); 21(11): 1-3.

Bammera Ch, Sperr W, Kemmler G,Wimazal F, Nösslinger T, Schönmetzler A, Krieger O, Pfeilstöcker M, Valent P, Stauder R. Clustering of comorbidities is related to age and sex and impacts clinical outcome in myelodysplastic syndromes. Journal of Geriatrics Oncology. (2014); 5(3): 299-306.

Deschler B, Ihorst G, Platzbecker U, Germing U, März E, Figuerido M, Fritzsche K, Haas P, Salih H, Giagounidis A, Selleslag D, Labar Witte T, Wijermans P, Lübbert M. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica. (2013); 98(2): 208-216.

Buckstein R, Wells R, Zhu N, Leitch H, Nevill T, Yee K, Leber B, Sabloff M, Hilaire E, Kumar R, Geddes M, etc. Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study. British Yournal of Haematology. (2016); 174(1): 88-101.

Ria R, Moschetta M, Reale A, Mangialardi G, Castrovilli A, Vacca A, Dammacco F. Managing myelodysplastic symptoms in eldery patients. Clinical Interventions in Aging. (2009); 4: 413-423.



  • There are currently no refbacks.

Copyright (c) 2019 © The Authors

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

POL-index 2011 - 2014

BASE 2011 - 2014

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

Find a library that holds this journal:

Journal Language(s): English 

PBN Poland



Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2 Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase


Universal Impact Factor 1.78 for year 2012. (

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ)

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski